Loss of expression of NEFH was first found in prostatic tumors 25, while epigenetic alterations of NEFH have initially been reported in the context of “field cancerization” to occur as premalignant DNA-methylation events detectable in normal epithelial cells of tissues at higher tumor risk 26. The gene discussed is NEFH; the disease is prostate neoplasm.